|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
� |
|
��֢ |
| ��������������� | |
|
��ǿ |
|
���� |
|
��¡�� |
| PubMed | |
|
Article by |
|
Article by |
|
Article by |
���֢�������Ƶ��о���չ
��ǿ, ����, ��¡��
�й�ҽѧ��ѧԺ���й�Э��ҽ�ƴ�ѧƤ�����о��� �Ͼ� 210042
��֢�����������Ҫ�������,������֢�ǿ��������Ҫ����,Ȼ���䷢��������δ��ȫ���ˡ������������֢������о�ȡ��������µĽ�չ���������˾������õõ���һ��������,����֢���ӡ�֬�ʡ�����ϩB4����������ø�������Ｄ������-���������صȾ����������֢�йء����ҳ����������ϵͳ��,��������ϵͳҲ��������֢�ķ��������֢�������ƵIJ��Ͻ�ʾ��Ϊ������ṩ����µ����ư�λ��
[2] Layton AM, Morris C, Cunliffe WJ, et al. Immunohistochemical investigation of evolving inflammation in lesions of acne vulgaris. Exp Dermatol, 1998, 7:191-197.
[3] Akamatsu H, Horio T. The possible role of reactive oxygen species generated by neutrophils in mediating acne inflammation. Dermatology, 1998, 196:82-85.
[4] Webster GF. Inflammatory acne represents hypersensitivity to Propionibacterium acnes. Dermatology, 1998, 196:80-81.
[5] Burkhart CG, Cantrill J, Butcher CL, et al. Propionibacterium acnes: interaction with complement and development of an enzymelinked immunoassay for the detection of antibody. Int J Dermatol,1999, 38:200-203.
[6] Leyden JJ, McGinley KJ, Vowels B. Propionibacterium acnes colonization in acne and nonacne. Dermatology, 1998, 196:55-58.
[7] Zouboulis CC. Is acne vulgaris a genuine inflammatory disease? Dermatology, 2001, 203 (4): 277-279.
[8] Zouboulis CC, Xia LQ, Detmar M, et al. Culture of human sebocytes and markers of sebocytic differentiation in vitro. Skin Pharmacol,1991,4:74-83.
[9] Akai Y, Akamatsu H, Neitzel H, et al. Culture of human sebocyte and markers of sebocytic differentiation in vitro. Jpn J Dermatol,1994, 104:674-679.
[10] Akamatsu H, Niwa Y, Matsunaga K. Effect of palmitic acid on neutrophil functions in vitro. Int J Dermatol, 2001, 40:640-643.
[11] Wozel G, Chang A, Zultak M, et al. The effect of topical retinoids on the leukotriene-B4-induced migration of polymorphonuclear leukocytes into human skin. Arch Dermatol Res, 1991, 283:158-161.
[12] Bohm M, Luger TA. The pilosebaceous unit is part of the skin immune system. Dermatology, 1998, 196:75-79.
[13] Kupper TS, Groves RW. The interleukin-1 axis and cutaneous inflammation. J Invest Dermatol, 1995, 105: S62-S66.
[14] Groves RW, Rauschmayr T, Nakamura K, et al. Inflammatory and hyperproliferative skin disease in mice that express elevated levels of the IL-1 receptor (type I) on epidermal keratinocytes. Evidence that IL-1-inducible secondary cytokines produced by keratinocytes in vivo can cause skin disease. J Clin Invest, 1996, 98:336-344.
[15] Kozlowska U, Blume-Peytavi U, Kodelja V, et al. Vascular endothelial growth factor expression induced by proinflammatory cytokines (interleukin 1 alpha, beta) in cells of the human pilosebaceous unit.Dermatology, 1998, 196:89-92.
[16] Koreck A, Pivarcsi A, Dobozy A, The role of innate immunity in the pathogenesis of acne. Dermatology, 2003, 206:96-105.
[17] Kim J, Ochoa MT, Krutzik SR, et al. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol, 2002,169:1535-1541.
[18] Vega B, Jomard A, Michel S. Regulation of human monocyte Tolllike receptor(TLR2) expression by adapalene. J Eur Acad Dermatol Venereol, 2002,16:123-124.
[19] Bonish B, Jullien D, Dutronc Y,et al. Overexpression of CDld by keratinocytes in psoriasis and CD1 d-dependent IFN-gamma production by NK-T cells. J Immunol, 2000, 165:4076-4085.
[20] Godfrey DI, Hammond KJ, Poulton LD,et al. NKT cells: facts, functions and fallacies. Immunol Today, 2000, 21:573-583.
[21] Devchand PR, Keller H, Peters JM, et al. The PPARalpha-leukotriene B4 pathway to inflammation control. Nature, 1996, 384:39-43.
[22] Toyoda M, Morohashi M. New aspects in acne inflammation. Dermatology, 2003, 206:17-23.